AstraZeneca Gets CDSCO Approvals For Liver Cancer Drug in India
New Delhi: The Central Drugs Standard Control Organisation (CDSCO) has authorised AstraZeneca Pharma India’s Tremelimumab Concentrate for intravenous administration, the
Read More
CDSCO
Marion Biotech stops producing Dok 1 Max cough syrup, CDSCO Inspects
New Delhi: There have been reports from Uzbekistan of contaminated Dok 1 Max cough syrup from Indian company Marion Biotech,
Read More